Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Smoking Cessation 1 Neoplasms, Second Primary 1 Behavior, Addictive 1

Interventions

pembrolizumab 512 Specimen Handling 381 Carboplatin 371 Magnetic Resonance Spectroscopy 333 Cisplatin 327 Nivolumab 302 Cyclophosphamide 295 Radiotherapy 254 Paclitaxel 252 Biopsy 235 Gemcitabine 229 Bevacizumab 212 Dexamethasone 167 durvalumab 162 Oxaliplatin 160 Capecitabine 154 Rituximab 151 Fluorouracil 148 venetoclax 142 atezolizumab 141 Docetaxel 141 Drug Therapy 140 Etoposide 138 Doxorubicin 131 Ipilimumab 125 Radiosurgery 118 Lenalidomide 117 Prednisone 116 Leucovorin 111 fludarabine 109

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Nicotine Chewing Gum × 1 year × Clear all

NCT04634071 2026-02-02

TTOP

University of Kentucky

Phase 2 Completed

Smoking Cessation, Neoplasms, Second Primary, Behavior, Addictive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡